FindTrial
Sign In

Determing the presence of thalassemia in newborns using a cutoff value of less than or equal to 15%.

Prevalance of B globin gene mutation in newborns using cutoff value of less than or equal to 15% of hemoglobin A

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025510
Enrollment
600
Registered
2020-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All intramural healthy term neonates born on even days of the month.

Exclusion criteria

Exclusion criteria: 1.Neonates who have received blood transfusion prior to obtaining blood sample. 2.Neonates found to be having other hemoglobin variants during screening. 3.Neonates born on odd days of the month.

Design outcomes

Primary

MeasureTime frame
Prevalance of beta globin gene mutation in healthy term neonates identified by using a cutoff of less than or equal to 15%.Timepoint: At birth,6,10 and 14 weeks.—

Secondary

MeasureTime frame
Elucidation of genotype and phenotype correlation.Timepoint: At birth 6, 10 and 14 weeks.—

Countries

India

Contacts

Public ContactShreshta S Prabhan

Maulana Azad Medical College

drseemakapoor@gmail.com9013105457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026